Oncoinvent ASA

Oncoinvent ASAverified

0RU5.L

Oncoinvent ASA engages in the development of biopharmaceutical product for cancer therapy. It focuses on developing a pipeline of AXL kinase inhibitors. Its lead product bemcentinib, is a selective and orally bio-available small molecule AXL inhibitor. The company was founded by James Bradley Lorens and David R. Micklem on December 21, 2007 and is headquartered in Bergen, Norway.

Industry

Medical - Pharmaceuticals

IPO Date

2017-12-13

Stock Exchange

LSE

Ticker

0RU5.L

The Current Ratio as of December 2025 (TTM) for Oncoinvent ASA (0RU5.L) is 4.39

According to Oncoinvent ASA’s latest financial reports and current stock price. The company's current Current Ratio is 4.39. This represents a change of -2.14% compared to the average of 4.48 of the last 4 quarters.

Oncoinvent ASA (0RU5.L) Historical Current Ratio (quarterly & annually)

How has 0RU5.L Current Ratio performed in the past?

The mean historical Current Ratio of Oncoinvent ASA over the last ten years is 6.93. The current 4.39 Current Ratio has changed 6.23% with respect to the historical average. Over the past ten years (40 quarters), 0RU5.L's Current Ratio was at its highest in in the June 2017 quarter at 16.87. The Current Ratio was at its lowest in in the June 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

6.93

Median

6.86

Minimum

2.14

Maximum

11.29

Oncoinvent ASA (0RU5.L) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Oncoinvent ASA Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 107.61%

Maximum Annual Current Ratio = 11.29

Minimum Annual Increase = -69.11%

Minimum Annual Current Ratio = 2.14

Quarterly (TTM)
Annual
YearCurrent RatioChange
20244.7929.01%
20233.7173.54%
20222.14-69.11%
20216.92-37.34%
202011.05107.61%
20195.32-41.55%
20189.10-19.38%
201711.2937.91%
20168.1920.43%
20156.80-50.05%

Oncoinvent ASA (0RU5.L) Average Current Ratio

How has 0RU5.L Current Ratio performed in the past?

The current Current Ratio of Oncoinvent ASA (0RU5.L) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.55

5-year avg

5.72

10-year avg

6.93

Oncoinvent ASA (0RU5.L) Current Ratio vs. Peers

How is 0RU5.L’s Current Ratio compared to its peers?

Oncoinvent ASA’s Current Ratio is greater than Arecor Therapeutics plc (2.05), less than Imugene Limited (0), greater than Yext, Inc. (1.88), less than null (0), greater than null (1.09),

CompanyCurrent RatioMarket cap
2.05N/A
0N/A
1.88$1.07B
0N/A
1.09N/A

Build a custom stock screener for Oncoinvent ASA (0RU5.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncoinvent ASA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncoinvent ASA (0RU5.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncoinvent ASA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Oncoinvent ASA's Current Ratio?

How is the Current Ratio calculated for Oncoinvent ASA (0RU5.L)?

What is the highest Current Ratio for Oncoinvent ASA (0RU5.L)?

What is the 3-year average Current Ratio for Oncoinvent ASA (0RU5.L)?

What is the 5-year average Current Ratio for Oncoinvent ASA (0RU5.L)?

How does the current Current Ratio for Oncoinvent ASA (0RU5.L) compare to its historical average?